Skip to main content
Press release June 9, 2026

CVRx Announces Chief Financial Officer Transition

CVRx, Inc. (CVRX)

MINNEAPOLIS, June 09, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Jared Oasheim,
View original release